Connect with us


Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange



VANCOUVER, British Columbia, Oct. 16, 2020 (GLOBE NEWSWIRE) — MYDECINE INNOVATIONS GROUP, INC., (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”) is pleased to announce the appointment of UK-based Boustead Capital Markets LLP (“Boustead”) to commence the dual listing process on the London Stock Exchange (“LSE” or the “Exchange”) for the admission of the Company’s common shares to the Standard Segment of the Official List’s Main Market.

Among the factors considered by the Company in pursuing the dual listing, Mydecine™ noted that the LSE currently has a limited number of sizable psychedelics-focused biotech companies. Mydecine, as a contributing member to Drug Science UK, the only completely independent, science-led drugs charity, believes the LSE listing will provide UK and European investors with greater, more local exposure to a new high-quality investment choice of a business type not currently available on the Exchange.


Mydecine’s appointment of Boustead enables it to commence the LSE listing process and act on its intention for the Company’s common shares to trade on the Main Market in the next few months. In addition to its current listings in Canada, the United States, and Germany, the Company believes that a listing on the LSE makes it well-positioned to bring European investors into the Company’s share register.

The LSE listing is expected to provide all investors access and exposure to:

  • European Investor base in what the Company believes are Psychedelic-friendly countries such as the Netherlands, United Kingdom, Austria, and Portugal, to name a few
  • Support early and late-phase clinical trials
  • Expansion of the Company’s telehealth platform; Mindleap Health
  • Further development of extensive IP portfolio
  • Furthering the development of novel types of psilocybin-based medicine and unique formulations

Josh Bartch, CEO & Chairman of Mydecine Innovations Group, commented, “The Board of Directors has met a number of times deciding the best route and venue for the new listing of the Company’s securities, adding to our focus on shareholder value. We decided the LSE represented the best stock exchange for our investors, shareholders, and the ongoing growth of the Company. Additionally, it provides a great platform to measurably advance our investor reach within the European investor community. A LSE Listing offers a number of opportunities to fast-track further potential listings to exchanges such as NASDAQ or NYSE. Mydecine Innovations Group has a global reach through the Company’s various planned clinical trials, research facilities, partners and scientific advisors, some of which are located directly in the UK.”

About the London Stock Exchange
The London Stock Exchange was founded in 1571 during the reign of Elizabeth I in London, England. The LSE is the 4th largest exchange in the world (based on total market value of its listed companies) and is currently ranked 7th in overall liquidity. As of August 2020, the companies listed on the London Stock Exchange have a combined market capitalisation of ~$4 trillion USD (GBP ~£3,084,232,000,000). Its current premises are situated in Paternoster Square close to St Paul’s Cathedral. It is part of publicly traded London Stock Exchange Group (LSEG).

About Boustead & Company Limited
Boustead & Company Limited is a diversified and comprehensive non-bank financial institution with offices in Los Angeles, New York, San Francisco, London, and Beijing that is rapidly expanding in growth markets throughout the US and Asia. Through its principals and fully licensed subsidiaries, Boustead & Company possesses rich experience and exceptional capabilities in capital markets deal execution and provides best-in-class one-stop financial services to clients. Boustead’s comprehensive financial services platform consists of four operating units: Boustead Securities, LLC a US-based FINRA Broker/Dealer and middle-market investment bank; Sutter Securities Group, Inc., which owns four FINRA-regulated entities: Sutter Securities, Inc., Sutter Securities Clearing, LLC and FlashFunders Funding Portal, LLC, along with Sutter Securities Financial Services, Inc., Sutter Capital Partners, LLC a California Registered Investment Advisor; and Boustead Capital Markets LLP, regulated as an appointed representative in the UK. For more information, please visit
On behalf of Boustead & Company

Dan McClory, CEO

About Boustead Capital Markets, LLP
Boustead Capital Markets, LLP, based in London, advises on a wide array of corporate finance assignments across many industries, and is an appointed representative of Thornbridge Investment Management LLP which is authorised and regulated by the FCA. Boustead Capital Markets is a majority-owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution.
On behalf of Boustead Capital Markets,

David Peerless, Director

About Mydecine Innovations Group Inc.
Mydecine Innovations Group™ (CSE: MYCO) is a publicly traded life sciences syndicate, with offices in Denver, CO, USA and Vancouver, BC, Canada. Mydecine is dedicated to the development and production of adaptive pathway medicine and natural health products all stemming from mushrooms. Mydecine’s experienced multi-talented team has the dynamic capabilities to oversee all areas of Schedule I drug development, including but not limited to synthesis, genetic research, delivery mechanism design, clinical trial execution; through to worldwide product commercialization, marketing and spore-to-sale distribution of cGMP psilocybin API’s and non-psychedelic medicinal fungi. By leveraging strategic partnerships with global scientific, medical, clinical, and Veteran organizations; Mydecine is well positioned at the forefront of naturally derived medicine, alternative therapeutics, and fungtional™ mushroom vitality consumer goods. Our portfolio of unified companies, including Mydecine Health Sciences™, Mindleap Health™, and NeuroPharm™ focus together on providing innovative and effective solutions that can help millions of people live a healthier quality life.

For further information about Mydecine Innovations Group, Inc., please visit the Company’s profile on SEDAR at or visit the Company’s website at

On behalf of the Board of

Joshua Bartch, Chief Executive Officer

Corp Communication:
Charles Lee, Investor Relations

Public Relations:
Cynthia Salarizadeh, Public Relations

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, without limitation, the availability and continuity of financing, the ability of the Company to adequately protect and enforce its intellectual property, the Company’s ability to bring its products to commercial production, continued growth of the global adaptive pathway medicine, natural health products and digital health industries, and the risks presented by the highly regulated and competitive market concerning the development, production, sale and use of the Company’s products. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon.


Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Aaron Wudrick: Chrystia Freeland comes bearing good news




Article content continued

If all that doesn’t worry you enough, consider Freeland citing journalist Kevin Carmichael’s line that “it’s unfair to saddle the next generation with our debt, but it would be worse to bequeath them a weak economy.”

The unstated assumption, of course, is that the government has either the capacity or wisdom to simply “make” a strong economy to bequeath.

Set aside for a moment whether this is possible in theory. What has the Trudeau government’s track record on this front been in practice? It can’t provide any paperwork for a staggering 20,000 infrastructure projects. Its billion-dollar “innovation superclusters” project is failing to hit every single one of its promised targets. The much-hyped Strategic Innovation Fund was supposed to create 56,000 jobs at a cost of $2.3 billion, but instead produced 11,300.

Which part of this terrible track record should inspire confidence?

Exactly which part of this terrible track record should inspire confidence that when it comes to reshaping an entire economy, they’re going to get it right?

Freeland asserts any and all spending is an unalloyed good, to which any objection can be safely framed as heretical. She suggests a binary choice between a debt-funded sunlit upland and a dystopian hellscape of “austerity.” And she seeks to pre-empt pressure to wind down spending after the pandemic ends by asserting that whatever the government continues to spend will, by definition, be critical to “laying a foundation” for the economy of tomorrow. It is a speech that pledges literally nothing but spending today and spending tomorrow with a vague shrug that someday, maybe, we’ll stop.

The finance minister, a keen student of history, noted that it is a poor general who fights the last war. But if government debt was the enemy in the last war, Freeland is betting on an immensely risky proposition that the former adversary is now a friend. If she’s wrong, Canada will be both weighted down with mounting debt and mired in a struggling economy.

Aaron Wudrick is federal director of the Canadian Taxpayers Federation.

Source link

Continue Reading


Conservative leader says party must take financial inequality more seriously – National




OTTAWA — Conservative Leader Erin O’Toole took aim Friday at what he called financial elites, saying his own party needs to take inequality more seriously and to support ongoing emergency aid.

He used the midday speech to a largely business audience to say that how the country creates wealth needs to be reframed, or else “less reasonable” forces will do it instead.

“Too much power is in the hands of corporate and financial elites who are happy to outsource jobs abroad,” O’Toole warned the Canadian Club of Toronto, according to his text.

“It’s now expected of a shareholder to ask a CEO: ‘Why are we paying a worker in Oshawa $30 an hour when we could be paying one in China 50 cents an hour?’ And while that shareholder gets richer, Canada gets poorer.”

Read more:
Income inequality in Canada divided along racial lines, new report says

Story continues below advertisement

O’Toole blamed the Liberals for favouring elites over workers, trade deals over domestic jobs.

The Opposition leader gave the broad strokes of how the Tories would tackle an economic divide widened by the pandemic, with higher-income earners faring better than low-wage workers.

O’Toole said government policy should focus on building “solidarity,” not just wealth, and talked about the need to intervene in the economy when good outcomes aren’t shared, or when it was in the national interest.

Click to play video 'Coronavirus: Tam says pandemic has ‘shone a spotlight’ on inequalities in Canada’s health-care system'

Coronavirus: Tam says pandemic has ‘shone a spotlight’ on inequalities in Canada’s health-care system

Coronavirus: Tam says pandemic has ‘shone a spotlight’ on inequalities in Canada’s health-care system

He also a mirrored a call from Liberal Finance Minister Chrystia Freeland, for ongoing aid to combat the health and economic crisis brought on by COVID-19.

“I don’t like deficits. But the alternatives were much worse. We had to do what needed to be done,” O’Toole said.

Story continues below advertisement

“This is not something I would support in normal times. But we are facing more than a health crisis. We are facing the greatest economic crisis of our lifetime.”

Read more:
ILO report shows increasing income inequality — Where does Canada stand?

In the question-and-answer session after his speech, O’Toole added that he doesn’t support the depth of the deficit the Liberals have created.

Freeland’s department produced an update Friday on how much the federal government has borrowed to supply that aid so far.

The federal deficit hit $170.5 billion through the first five months of the government’s fiscal year. The deficit figure from April to August compared to a $5.2-billion deficit recorded in the same period one year earlier, thanks to billions of dollars in spending on emergency aid.

The monthly fiscal monitor from the Finance Department showed the Canada Emergency Response Benefit payments at $58.8 billion and the federal wage subsidy program at $37.4 billion over the five-month stretch.

Click to play video 'The Age of Increasing Inequality'

The Age of Increasing Inequality

The Age of Increasing Inequality

A further $19.2 billion in spending over that time included money for a business loan program the Liberals have since widened and a rent-relief program for businesses the government plans to revamp.

Story continues below advertisement

Read more:
Women earn less than men in Canada right after graduation — then it gets worse: report

The deficit numbers landed just after Statistics Canada reported the pace of economic growth slowed in August, and offered a preliminary estimate that it had slowed further in September. If the figures hold, the growth in gross domestic product for the the third quarter would be about 10 per cent.

O’Toole said federal spending should focus on preserving Canada’s economic potential.

“That should be our approach, growing the GDP, having more people working, and getting a balance to our fiscal situation _ a balance over the next decade _ ramp down program spending in a way that’s fair and equitable,” O’Toole said.

“If people aren’t working when they come off CERB, we’re going to see a prolonged debt crisis in Canada, and we’re gonna see more capital leave our country rather than come to it.”

Click to play video 'Trudeau empathizes with G20 protesters over economic inequality'

Trudeau empathizes with G20 protesters over economic inequality

Trudeau empathizes with G20 protesters over economic inequality

The Canada Emergency Response Benefit was the Liberal government’s $500-a-week relief payment to people who lost work in the first months of the pandemic. Its replacement, known as the Canada Recovery Benefit, has paid out $1.48 billion to over 917,000 people since it launched. A further $1.15 billion has been paid in EI benefits among the nearly 1.6 million claims approved out of the 1.8 million claims filed.

Story continues below advertisement

The figures provide a partial view of the labour force ahead of next week when Statistics Canada will release the unemployment rate for October. The rate was nine per cent in September.

Freeland, in a speech of her own to Montreal’s chamber of commerce, said the Liberals will soon introduce legislation to provide more economic aid, including extending the wage subsidy to next summer, and help for businesses subject to lockdown orders.

“We urge all parliamentarians to join us in approving these critical measures,” she said, noting the support for income-support changes enacted last month.

“I hope we can all take the same Team Canada approach with these support measures for our small businesses.”

© 2020 The Canadian Press

Source link

Continue Reading


TIMIA Capital Announces Third Quarter 2020 Financial Results




~Company’s growth profile continues with record quarterly revenue~

VANCOUVER, BC, Oct. 30, 2020 /CNW/ – TIMIA Capital Corporation (“TIMIA” or the “Company”) (TSXV: TCA) (OTC: TIMCF) today announced consolidated financial results for the third quarter ended August 31, 2020. All figures are reported in Canadian dollars unless otherwise noted.

Third Quarter 2020 Highlights include:

  • Record total revenue of $1.4 million, up 56% over the same period last year.
  • Posted interest income from investments of $1.3 million, included in total revenue, an increase of 46% year over year.
  • Total assets increased 37% to $37.0 million as at August 31, 2020 compared to November 30, 2019. Cash balance, as part of assets, was $8.2 million compared to $4.7 million as at November 30, 2019.
  • TIMIA’s loan investment portfolio (loans receivable) increased by 26% to $27.3 million in comparison to the same period last year.
  • During the third quarter 2020 the Company received approximately $10 million (US$7.5 million) in subscription agreements towards a second Limited Partnership (“LP II”).
  • Reported consolidated net income of $333,243, which includes a significant unrealized foreign exchange loss of $747,259, compared to a consolidated net loss of $54,658 for the same period last year. Outside of foreign exchange impacts, the improvement in consolidated net income on a year-over-year basis is representative of the increase in total revenue plus gains on investments.
  • The portion of consolidated net loss attributable to the shareholders of the company is $23,580 as compared to $189,781 for the same period last year.

On a comprehensive basis:

  • Reported consolidated net comprehensive loss of $73,584 compared to a consolidated net comprehensive loss of $54,658 for the same period last year. The current year includes a new foreign currency translation adjustment for the consolidation of the Company’s LP II, which held its first close in July, 2020 and is denominated in US$.

“We are reporting very strong third quarter 2020 results with record total revenue, a 56% growth over Q3 2019, along with a 66% increase in total assets versus the same period in 2019,” said Mike Walkinshaw, CEO of TIMIA Capital Corporation. “These strong results in the midst of the COVID-19 pandemic demonstrate the resiliency of the Company’s model.   Our proprietary fintech platform continues to perform beyond expectations with a single loan exit and resulting gain on investment during the third quarter, and with four additional exits during the subsequent two months of the fourth quarter.  For the year to date, the Company has seen seven exits from its portfolio and a combined gain of approximately $1.6 million. With these exits and the $10 million raised in our second Limited Partnership, we have the necessary capital to continue our growth initiatives.”

Portfolio and Revenue Review

The Company’s investment portfolio has continued to deliver returns in accordance with the underlying loan agreements during the quarter.  For the 9 month period ended August 31, 2020, TIMIA has completed 6 new investments and has had 3 companies exit their loan facilities bringing the loan portfolio to 21 companies and a loan book of $27.3 million.

Subsequent to the end of the 3rd quarter, the Company has completed 2 new investments and seen exits from a further 4 portfolio companies.  Year to date, the Company has seen total gains of approximately $1.6 million based upon the 7 exited portfolio companies and has completed 8 new investments.

Interest income earned from the portfolio in the three months ended August 31, 2020 was $1.3 million compared to $0.9 million in the same period last year, a 46% increase.  Income from transaction and other fees was $123,513 in the three months ended August 31, 2020 compared to $26,644 in the same period last year. The change in transaction and other fees reflects an increase in investing activity after having taken a pause on these activities during the initial phases of COVID-19 in Q2. Reflecting the increase in transaction fee revenue, total revenue for the three months ended August 31, 2020 increased 56% to $1.4 million compared to $0.9 million for the three months ended August 31, 2019.

Impact of Foreign Exchange

The Company generated significantly positive financial returns this past quarter but also experienced foreign exchange headwinds related to the Canadian US dollar exchange rate.  During the third quarter, the Canadian US dollar exchange rate declined by approximately six cents to its lowest point of approximately 1.30 at quarter end.   The Company has hedged a substantial portion of the foreign exchange risk related to common shareholders, however the limited partners of LP I and LP II have chosen to bear the risk of foreign exchange swings.  These foreign exchange losses are reflected in our consolidated net income of $333,243, our consolidated comprehensive net loss of $73,584 as well as the net income attributable to non-controlling interests of $356,823.  Consolidated net income, prior to unrealized foreign exchange losses and the offsetting gains from the forward contract, was $894,252*.

Subsequent to quarter end, the Canadian US $ exchange rate has reversed a portion of its decline, increasing by approximately 300 basis points to 1.33 as of today’s date.

Operational and Interest Expenses.

The Company is investing to support its future growth and the continued development of its fintech platform.  Total expenses, including interest expense, for the quarter ended August 31, 2020 were $1.0 million compared with $0.9 million for the same period last year. The change reflects a decrease in expected credit loss, investor relations and communications, and share-based compensation, offset by increases in accounting and legal, administrative, management, and director fees, amortization,  interest expense, marketing services and promotion, and office, travel, systems, and miscellaneous expenses, year-over-year.

Balance Sheet

As at August 31, 2020, the Company’s consolidated cash balance was approximately $8.2 million and consolidated working capital was approximately $3.6 million, compared with approximately $4.7 million and $4.6 million, respectively, as of November 30, 2019. The change in working capital at quarter end reflects the nearing maturity of certain of the debentures and convertible debentures.  Subsequent to quarter end, these convertible debentures matured on October 7th, 2020.  In settlement of these debentures and in accordance with the instructions of the individual debenture holders, the Company converted $530,000 of these debentures to common shares at $0.14 per share, repaid $887,500 in the form of cash, and extended the maturity of $663,500 of debentures to Nov 27th, 2020 in order to allow for the potential exchange into a proposed offering of preferred shares. There is no guarantee that the proposed offering of preferred shares will be completed.

Net Loss Attributable to Common Shareholders

The Company has generated strong returns for its non-dilutive investors benefiting common shareholders by earning a portion of those returns in the form of management fees, recovery of administrative costs, and performance fees.  As the size of the loan book increases, these fees should also increase. In the current quarter, the net loss attributable to common shareholders is $23,580 as compared to $189,781 in the same period prior year.  Management expects continued improvement in net income attributable to common shareholders in the coming quarters.   

This news release is qualified in its entirety by the Company’s condensed interim financial statements for the three months ended August 31, 2020 and August 31, 2019 and the associated Management’s Discussion & Analysis respecting the same periods, which can be downloaded from the Company’s profile on SEDAR at

COVID-19 Update
TIMIA is providing an update with respect to the impact from the COVID-19 virus outbreak on its current operations. To date, there have been no known cases of COVID-19 at any of TIMIA’s offices.

Management believes that recurring revenue software companies offer security and stability. The Company utilizes a proprietary credit scoring process that focuses on high customer retention rates as well as a well-diversified customer base. These two factors, along with other key attributes such as size and cash runway, are structured to provide downward protection in an uncertain economic environment. Many of our portfolio companies have been agile in this environment, including in many instances transitioning employees to work remotely. At this time, none of the Company’s investments are in arrears. However, it may be several months before the full effect of the economic slowdown is felt in the portfolio. Management is in the process of reviewing revised and updated forecasts for each of the portfolio companies and are working with them to determine the best way to support them through the crisis. Management has decided to increase the size of our capital reserves thereby reducing our allocation to new deals

TIMIA has been a remote-friendly working environment since its formation.  Our employees have been able to transition seamlessly to working from home and have been able to maintain close contact and relationships with current portfolio companies and new and exciting SaaS investment opportunities.

* Defined as net income removing foreign exchange loss and the gain on forward contract.

About TIMIA Capital Corporation
TIMIA Capital Corporation is a specialty finance company that provides growth capital to technology companies in exchange for payments based on monthly revenue. This alternative financing option complements both debt and equity financing, while allowing entrepreneurs and existing stakeholders to retain ownership and control of their business. TIMIA’s singular focus is the fast growing, global, business-to-business Software-as-a-Service (or SaaS) segment. We align ourselves with entrepreneurial management teams growing their sales from $2 Million to $20 Million in Annual Recurring Revenue. For more information about TIMIA Capital Corporation, please visit

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward-Looking Information
Certain information and statements in this news release contain and constitute forward-looking information or forward-looking statements as defined under applicable securities laws (collectively, “forward-looking statements”). Forward-looking statements normally contain words like ‘believe’, ‘expect’, ‘anticipate’, ‘plan’, ‘intend’, ‘continue’, ‘estimate’, ‘may’, ‘will’, ‘should’, ‘ongoing’ and similar expressions, and within this news release include any statements (express or implied) respecting the belief that as the size of the loan book increases fees should also increase, expectations as to  continued improvement in net income attributable to common shareholders in the coming quarters, beliefs that recurring revenue software companies offer security and stability, ,  expectations as to re-financing, extending or converting the debentures to equity, and statements about growing the Company’s business. Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions and other factors that management currently believes are relevant, reasonable and appropriate in the circumstances, including, without limitation, the following assumptions: that the Company and its investee companies are able to meet their respective future objectives and priorities, assumptions concerning general economic growth, the Company being able to obtain financing on acceptable terms, the Company’s ability to attract and retain skilled staff, the absence of unforeseen changes in the legislative and regulatory framework for the Company, the COVID-19 pandemic not having a material impact on the Company’s operations, the products and technology offered by the Company’s competitors and the Company’s ability to protect intellectual proprietary rights . Although management believes that the forward-looking statements are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to TIMIA’s business. Material risks and uncertainties applicable to the forward-looking statements set out herein include, but are not limited to, worldwide pandemics, such as the recent outbreak of the novel coronavirus COVID-19, may adversely impact multiple aspects of the Company’s business; the Company having insufficient financial resources to achieve its objectives; uncertainty as to the Company’s ability to raise additional funding; availability of further investments that are appropriate for the Company on terms that it finds acceptable or at all; successful completion of exits from investments on terms that constitute a gain when no such exits are currently anticipated; intense competition in all aspects of business; reliance on limited management resources; the Company’s dependence upon certain key personnel and their loss could adversely affect the Company’s ability to achieve its business objectives; general economic risks; new laws and regulations, risk of litigation, the Company may not achieve its publicly announced business objectives according to schedule, or at all; the Company’s success depending upon its ability to protect its intellectual property and its proprietary technology; the price of the Company’s shares may be subject to fluctuation in the future based on market conditions; the Company’s success depends on its ability to effectively manage growth; and significant disruptions of information technology systems or security breaches could adversely affect the Company’s business. Although Timia has attempted to identify factors that may cause actual actions, events or results to differ materially from those disclosed in the forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, predicted, estimated or intended. Also, many of the factors are beyond the control of Timia. Accordingly, readers should not place undue reliance on forward-looking statements. Timia undertakes no obligation to reissue or update any forward-looking statements as a result of new information or events after the date hereof except as may be required by law. All forward-looking statements contained in this news release are qualified by this cautionary statement.

SOURCE TIMIA Capital Corp.

For further information: Darren Seed, Vice President, Capital Markets & Communications; Mike Walkinshaw, CEO, TIMIA Capital Corporation, (604) 398-8839, [email protected]

Related Links

Source link

Continue Reading